Correlation Between Aerovate Therapeutics and BCECN
Specify exactly 2 symbols:
By analyzing existing cross correlation between Aerovate Therapeutics and BCECN 215 15 FEB 32, you can compare the effects of market volatilities on Aerovate Therapeutics and BCECN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of BCECN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and BCECN.
Diversification Opportunities for Aerovate Therapeutics and BCECN
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aerovate and BCECN is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and BCECN 215 15 FEB 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BCECN 215 15 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with BCECN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BCECN 215 15 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and BCECN go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and BCECN
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 7.98 times more return on investment than BCECN. However, Aerovate Therapeutics is 7.98 times more volatile than BCECN 215 15 FEB 32. It trades about 0.01 of its potential returns per unit of risk. BCECN 215 15 FEB 32 is currently generating about 0.0 per unit of risk. If you would invest 1,628 in Aerovate Therapeutics on September 12, 2024 and sell it today you would lose (1,365) from holding Aerovate Therapeutics or give up 83.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 74.43% |
Values | Daily Returns |
Aerovate Therapeutics vs. BCECN 215 15 FEB 32
Performance |
Timeline |
Aerovate Therapeutics |
BCECN 215 15 |
Aerovate Therapeutics and BCECN Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and BCECN
The main advantage of trading using opposite Aerovate Therapeutics and BCECN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, BCECN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCECN will offset losses from the drop in BCECN's long position.Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |